Sleep Cycle Q1 2025: Sales and EBIT in line, subscriber softness persists - Redeye

Sleep Cycle delivered a Q1 report that was broadly in line with our expectations on both sales and EBIT, despite continued subscriber headwinds. The muted topline and subscriber growth reflect persistent weakness in the broader sleep health category on the App Store. However, we view the quarter as solid given Sleep Cycle’s ability to gain market share from competitors, highlighting strong product-market fit and execution.

Länk till analysen i sin helhet: https://www.redeye.se/research/1097519/sleep-cycle-q1-2025-sales-and-ebit-in-line-subscriber-softness-persists?utm_source=finwire&utm_medium=RSS